SAN DIEGO, Sept. 30, 2019 /PRNewswire/ -- Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company focused on developing potentially best-in-class, oral therapies for the treatment of chronic inflammatory and autoimmune diseases, today announced management's participation in the following investor and scientific conferences in October:

WINNIPEG, Sept. 30, 2019 /PRNewswire/ - Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH, OTC:MCUJF), a cardiovascular pharmaceutical company, is pleased to announce that through its subsidiary, Medicure International Inc., it has acquired the ownership of ZYPITAMAGTM (pitavastatin) tablets, from Cadila Healthcare Ltd., India

SUZHOU, China, Sept. 30, 2019 /PRNewswire/ -- CStone Pharmaceuticals ("CStone" or the "Company", HKEX: 2616) released pooled safety data from the Phase Ib (GEMSTONE-101) study of the Company's anti-PD-L1 antibody CS1001 in a poster presentation at the European Society of Medical Oncology 2019 Congress (ESMO 2019), demonstrating the promising safety and tolerability profi

STAMFORD, Conn., Sept. 30, 2019 /PRNewswire/ -- According to the National Breast Cancer Foundation, one in eight women will be diagnosed with

SAN DIEGO, Sept. 30, 2019 /PRNewswire/ -- Results from a study sponsored by Stemedica Cell Technologies, Inc., a global biotechnology company that uses allogeneic stem cells for ischemic conditions, form the basis for a peer-reviewed paper published in Stroke entitled "

DAVIS, Calif., Sept. 30, 2019 /PRNewswire/ -- Evolve BioSystems and the Regents of the University of California have jointly filed and served a patent infringement complaint against Abbott Laboratories.  The complaint regards Abbott's soon-to-be-launched product Similac Probiotic Tri-Blend.

NEW YORK, Sept. 30, 2019 /PRNewswire/ -- WebMD Health Corp., an Internet Brands company and the leader in health information services for consumers, physicians, and other healthcare professionals (HCPs), today announced that it has entered into an agreement to acquire Aptus Health.

BARCELONA, Spain, Sept. 30, 2019 /PRNewswire/ -- Rakuten Medical, a clinical-stage, global biotechnology company developing precision-targeted cancer therapies based on its proprietary, anti-cancer treatment platform, Illuminox™, released post-hoc analysis of safety, pharmacokinetic (PK), immunogenicity and exploratory biomarker data from its

MINNEAPOLIS, Sept. 30, 2019 /PRNewswire/ -- The pioneer of portable recreational oxygen since 2005, Oxygen Plus (O+), Inc. is excited to announce expanded availability of it

SAN JOSE, Calif., Sept. 30, 2019 /PRNewswire/ -- Aridis Pharmaceuticals, Inc. (Nasdaq: ARDS), a biopharmaceutical company focused on the discovery and development of novel anti-infective therapies to treat life-threatening bacterial infections, announced today that it has consummated a licensing agreement with Serum AMR, an affiliate of Serum International BV